A systematic review of GSH as an adjuvant therapy in Parkinson's disease identified one controlled trial 65 showing doubtful benefit
Mechanistically, BPC-157 appears to modulate the nitric oxide (NO) pathway, interact with growth hormone receptors, and influence several molecular pathways involved in angiogenesis, fibroblast migration, and collagen deposition
They can also be caused by coronary heart disease or valvular heart disease
[DOI] [PubMed] [Google Scholar] 22.Sun Y., Pu L.Y., Lu L., Wang X.H., Zhang F., Rao J.H
Springer, Singapore Niego AG, Rapior S, Thongklang N, Rasp O, Jaidee W, Lumyong S, Hyde KD (2021) Macrofungi as a nutraceutical source: promising bioactive compounds and market value
Patients arrive convinced its a silver bullet for everything from tendon pain to gut issues, yet the conversation always comes back to the same point: Theres no human clinical data